课题基金 / 基金详情

Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)

Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
衰老相关血管性认知障碍(VCI)的神经炎症机制
批准号:
9461247
负责人:
Nabil J Alkayed
金额:
$249.53万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-08-31

项目摘要

项目成果

Nabil J Alkayed的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Vascular cognitive impairment (VCI) is the second most common cause of dementia after Alzheimer's disease (AD). The mechanisms underlying VCI are poorly understood, with no specific therapy currently exists to prevent or treat VCI. We have previously observed increased expression and activity of the enzyme soluble epoxide hydrolase (sEH) in microvascular endothelium of human brain tissue from deceased patients with pre-mortem VCI. We have also observed in mice that high-fat diet (HFD)-induced type 2 diabetes causes a similar increase in cerebrovascular sEH. Our preliminary data demonstrate that transgenic mice with constitutive overexpression of human sEH in endothelium (Tie2-hsEH) have impaired spatial memory (Morris Water Maze), suggesting that endothelial sEH is causally linked to cognitive impairment. Proposed studies will determine if endothelial sEH upregulation impairs cognition by a neuro-inflammatory mechanism mediated by infiltration of brain tissue by monocyte-derived macrophages. Studies will also determine if mice with endothelial-specific deletion of sEH (Tie2-Cre/floxed-sEH) are protected from HFD-induced neuronal loss, neuroinflammation and cognitive impairment. Finally, we will use two different therapies, one aimed at inhibiting sEH and one aimed at preventing monocyte/macrophage infiltration, to determine if these agents can prevent (when given prior to cognitive decline) or reverse (when given after cognitive impairment) the age-related cognitive deficit in Tie2-hsEH mice and wild-type mice on HFD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
Training in Translational Science and Cardiovascular Research
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
  • 批准号:
    10478533
  • 项目类别:
  • 资助金额:
    $25.19万
  • 财政年份:
    2022
  • 负责人:
    Nabil J Alkayed
  • 依托单位:
海外基金